Delivery Order SPE2DB22D2009-SPE2DB25FM0XM
- Not listed
- The Defense Logistics Agency awarded a $23,458.54 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $10,678.35 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is scheduled for ultimate completion on September 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is...
- The Defense Logistics Agency awarded a $20,611.42 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, utilizing competitive procurement procedures. The contract is set to be completed by August 13, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Biktarvy is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $8,351.68 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, with a completion date of July 30, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $13,351.13. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the critical pharmaceutical...
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $15,248.99 and is scheduled for completion by August 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,243.43 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on June 2, 2025, with a completion date of June 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $33.7K delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The pharmaceutical will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $20,323.81 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0XMDelivery Order
The Defense Logistics Agency awarded a $13,093.45 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract, which is firm fixed price and non-set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. Biktarvy is an antiretroviral medication used to treat HIV, reflecting the pharmaceutical distributor's critical role in supplying specialized medications to federal healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen has established itself as a key federal vendor through its competitively awarded contracts supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The non-set-aside award demonstrates the company's capability to meet federal procurement requirements in open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 8/14/25 |